Adipocyte dysfunction plays a major role in the outcome of
obesity,
insulin resistance and related cardiovascular complications. Thus, considerable efforts are underway in the pharmaceutical industry to find molecules that target the now well-documented pleiotropic functions of adipocyte. We previously reported that the dietary
flavonoid phloretin enhances 3T3-L1 adipocyte differentiation and
adiponectin expression at least in part through
PPAR gamma activation. The present study was designed to further characterize the molecular mechanisms underlying the
phloretin-mediated effects on 3T3-L1 adipocytes using microarray technology. We show that
phloretin positively regulates the expression of numerous genes involved in lipogenesis and
triglyceride storage, including GLUT4, ACSL1, PEPCK1, lipin-1 and
perilipin (more than twofold). The expression of several genes encoding
adipokines, in addition to
adiponectin and its receptor, is positively or negatively regulated in a way that suggests a possible reduction in systemic
insulin resistance and
obesity-associated
inflammation. Improvement of
insulin sensitivity is also suggested by the overexpression of genes associated with
insulin signal transduction, such as CAP, PDK1 and Akt2. Many of these genes are
PPAR gamma targets, confirming the involvement of
PPAR gamma pathway in the
phloretin effects on adipocytes. In light of these microarray data, it is reasonable to assume that
phloretin may be beneficial for reducing
insulin resistance, in a similar way to the
thiazolidinedione class of
antidiabetic drugs.